Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor- |
RCV000210462 | SCV000266545 | pathogenic | Alstrom syndrome | criteria provided, single submitter | research | ||
Labcorp Genetics |
RCV000210462 | SCV001587242 | pathogenic | Alstrom syndrome | 2024-01-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg3706Leufs*11) in the ALMS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALMS1 are known to be pathogenic (PMID: 17594715). This variant is present in population databases (rs398122992, gnomAD 0.03%). This premature translational stop signal has been observed in individual(s) with Alstrom syndrome (PMID: 24595103, 26047050). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as c.11110_11128del (p.R3704LfsX11). ClinVar contains an entry for this variant (Variation ID: 92191). For these reasons, this variant has been classified as Pathogenic. |
Johns Hopkins Genetic Resources Core Facility; Johns Hopkins University | RCV000077807 | SCV000109647 | not provided | not provided | no assertion provided | not provided | ||
Natera, |
RCV000210462 | SCV002078997 | pathogenic | Alstrom syndrome | 2021-09-29 | no assertion criteria provided | clinical testing |